Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'

Creative Commons License

SATIŞ H., AYDEMİR E., İZMİRLİOĞLU K., TUFAN A.

Annals of the rheumatic diseases, cilt.81, sa.12, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 81 Sayı: 12
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1136/annrheumdis-2020-218901
  • Dergi Adı: Annals of the rheumatic diseases
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: amyloidosis, familial Mediterranean fever, interleukin 1 receptor antagonist protein, inflammation
  • Gazi Üniversitesi Adresli: Evet